Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer

By Reding Kerryn  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 491-498

Springer Publishing Company

Access to resources Recommend Favorite

Oral contraceptive use and the risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations

By Gillanders William   Simon Jr Peter  

The Women's Oncology Review, Vol. 5, Iss. 2, 2005-06 ,pp. : 127-128

Informa Healthcare

Access to resources Recommend Favorite

Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer

By Cavallone Luca  

Familial Cancer, Vol. 9, Iss. 4, 2010-12 ,pp. : 507-517

Springer Publishing Company

Access to resources Recommend Favorite

Effect of BRCA1/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis

By Lee Eun-Ha  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 11-25

Springer Publishing Company

Access to resources Recommend Favorite

Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families

By Giannini Giuseppe   Capalbo Carlo   Ristori Elisabetta   Ricevuto Enrico   Sidoni Tina   Buffone Amelia   Cortesi Enrico   Marchetti Paolo   Scambia Giovanni   Tomao Silverio   Rinaldi Christian   Zani Massimo   Ferraro Sergio   Frati Luigi   Screpanti Isabella   Gulino Alberto  

Breast Cancer Research and Treatment, Vol. 100, Iss. 1, 2006-11 ,pp. : 83-91

Springer Publishing Company

Access to resources Recommend Favorite